China fines British drug maker GlaxoSmithKline $492 million, jails executives in bribery case

A state news agency says a Chinese court has fined British drug maker GlaxoSmithKline $492 million and sentenced its British former country manager and others to prison for bribing doctors and hospitals to use its products.

The Xinhua News Agency said the former country manager, Mark Reilly, and others were sentenced to two to four years in the case, which highlighted widespread payments to Chinese doctors by sellers of drugs and medical equipment.